GO
Loading...

Lightning Round: Isis Pharma, Himax & more

Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

Sysco (SYY): I think Sysco is heading higher, said Cramer. I'm a buyer.

Chimera Investment (CIM): It hasn't been a great place to put money, said Cramer. I would not recommend this stock.


Getty Images

Himax (HIMX): It was a great trade, said Cramer, but the trade is over. Don't look back.

Omeros Corp. (OMER): I need to do more homework on this stock before I can opine, said Cramer.

Trinity Industries (TRN): I don't like this, said Cramer. I'm worried that margins have peaked in the rail car business.

Pfizer (PFE): I think this is a fine stock, said Cramer. But I prefer Bristol-Myers.

Isis Pharma (ISIS): This is a long-term situation, said Cramer. I like the pipeline very much. In fact, I think it's one of the best pipelines in the industry. But it's a spec.

Lazard (LAZ): I'm a buyer, said Cramer. I think deals will keep coming.

Call Cramer: 1-800-743-CNBC
Questions for Cramer? madmoney@cnbc.com
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Mad Money Moments

Cramer's New Book